Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.
he gene-editing technology CRISPR could very well one day rid the world of its most devastating diseases, allowing us to simply edit away the genetic code responsible for an illness. One of the things standing in the way of turning that fantasy into reality, though, is the problem of off-target effects. Now Microsoft is hoping to use artificial intelligence to fix this problem.
An Ottawa-based firm has been tapped by the federal government for a three-month pilot project designed to look for warning signs for suicide before tragedy strikes.
Researchers say AI procedure was successful in detecting the spread of breast cancer. It’s the latest artificial intelligence innovation in the medical world.
WRN has been identified as a synthetic lethal target in highly microsatellite unstable (MSI-H) cancer cells, with therapeutic potential for MSI-H tumor patients who do not respond to existing therapies. The innovative module Alchemisty under Yingsi Intelligent Chemistry42 utilizes non-equilibrium switching method to accurately and quickly estimate the binding free energy of protein ligand complexes, simplifying and accelerating the optimization process of ISM2196. In preclinical studies, ISM2196 has demonstrated strong in vivo anti-tumor efficacy in various MSI-H cancer models, with good selectivity, safety, and ADMET (absorption, distribution, metabolism, excretion, and toxicity) characteristics. Yingsi Intelligent, a clinical stage biopharmaceutical technology company driven by generative artificial intelligence (AI), announced the nomination of preclinical candidate drug ISM2196, a potential “best in class” WRN inhibitor discovered by AI, aimed at treating advanced metastatic microsatellite instability (MSI) cancer through synthetic lethal strategies. The DNA helicase Werner (WRN) is a member of the RecQ helicase family ...
MRI scans to get ten folds faster as Facebook collaborates with New York University (NYU) School of Medicine to spearhead a research project for the same using artificial intelligence (AI).
Elliot K. Fishman, MD, professor of radiology, surgery, oncology and urology at Johns Hopkins Hospital seeks the help of GPU-accelerated deep learning artificial intelligence to detect pancreatic cancer early which is nearly impossible for humans alone.
Scientists from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy have designed an artificial intelligence based system to design new drug molecules from the scratch level.
In the latter part of this year, a code of conduct for the use of artificial intelligence (AI) in healthcare will be introduced by the NHS, England, announced Harpreet Sood, associate CCIO at NHS England, at The King’s Fund’s Digital Health and Care Congress 2018 on 11 July.
Artificial intelligence based company Viz.ai, currently developing software for the detection of urgent stroke cases, has recently raised $21 million in venture capital to develop its portfolio.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.